Prediction of lymph node metastasis risk by M2 tumor associated macrophages in colorectal cancer tissue
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9
Abstract
Objective To investigate the risk of lymph node metastasis (LNM) in colorectal cancer (CRC) based on the M2 macrophage activity biomarker soluble CD163 (sCD163). Methods The clinical data and preoperative blood samples of 152 patients with CRC and 58 patients with colorectal adenoma who received primary surgery in Jingmen Central Hospital from January 2018 to May 2019 were collected. Blood samples were collected the day before surgery, and enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of sCD163, carcinoembryonic antigen (CEA), and carbohydrate antigen 199 (CA199). Postoperative follow-up was conducted with a cutoff date of April 30, 2024, and the overall survival and disease-free survival were recorded. Results The level of sCD163 in patients without LNM was significantly lower than in those with LNM ［(2.79±0.76) mg/L vs (4.25±1.50) mg/L, t=7.958, P＜0.01］. Multivariate logistic regression analysis indicated that sCD163＞3.50 mg/L was an independent risk factor for LNM in CRC patients (HR=13.973, 95%CI: 5.385-36.259, P＜0.05). sCD163＞3.50 mg/L had the highest ability to predict lymph node metastasis in CRC patients (AUC=0.742), with a sensitivity of 68.8% and a specificity of 79.7%. There were 35 patients (46.1%) died in the group of sCD163＞3.50 mg/L, and 12 patients (15.8%) died in the group of sCD163≤3.50 mg/L. There was a significant difference in overall survival between the two groups (log-rank χ2=15.583, P＜0.01). There were 42 patients (55.3%) in the group of sCD163＞3.50 mg/L relapsed, and 25 patients (32.9%) in the group of sCD163≤3.50 mg/L relapsed. The difference in recurrence-free survival between the two groups was statistically significant (log-rank χ2=8.368, P=0.004). Conclusion Elevated levels of the biomarker sCD163, which reflects M2 macrophage activity in tissues, are significantly associated with LNM and poor prognosis in CRC patients, and sCD163 may be a potential predictive factor for identifying CRC patients at high risk of LNM.
Authors and Affiliations
ZHU Xiaoxuan, LONG Zhou, CAO Shaohua
Keywords
Related Articles
- EP ID EP745459
- DOI 10.13429/j.cnki.cjcr.2024.09.012
- Views 22
- Downloads 0
Temporary inferior vena cava filter combined with catheter contact thrombolysis in the treatment of acute pulmonary embolism secondary to pelvic vein thrombosis
Objective To investigate the treatment methods and efficacy of acute pulmonary embolism. Methods The diagnosis and treatment information of 8 patients with APE secondary to pelvic vein thrombosis admitted by the Changsh...
Association between serum pancreatic regenerating protien Ⅰα and the risk of chronic kidney disease in patients with diabetes mellitus
"<b>Objective</b> To investigate the correlation between serum pancreatic regenerating (Reg) protein Ⅰα and chronic kidney disease (CKD) in diabetic patients, to develop a risk prediction model for diabetes combined with...
Study on the medication rule of Chinese medicine compound oral administration for the treatment of alopecia areata based on the national patent database
<b>Objective</b> To explore the medication rules of patented Chinese medicine compounds for oral administration in treating alopecia areata (AA), and provide reference for the treatment of AA with Chinese medicine and t...
Advance in immune microenvironment and immunotherapy in triple-negative breast cancer
Breast cancer is the most common malignant tumor in women. Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by poor differentiation, high rate of progression and poor pr...
Research progress of esketamine and postoperative delirium
Postoperative delirium (POD) is a common complication in elderly patients after surgery, significantly affecting prognosis and increasing mortality rates. The underlying mechanisms of POD remain unclear, with diverse ris...